A similarly constructed study, including a photodynamic immunostimulant consisting of BMS-1 (PD-1 inhibitor), V9302, and chlorin e6 (a photosensitizing agent), showed anti-tumor activity in metastases due to increased recognition between CD8+T cells and Fas-overexpressing tumor cells [16]. This evidence concerns the gene CD8A and neoplasm.